These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 24956279)

  • 1. Immunization against multidrug-resistant Acinetobacter baumannii effectively protects mice in both pneumonia and sepsis models.
    Huang W; Yao Y; Long Q; Yang X; Sun W; Liu C; Jin X; Li Y; Chu X; Chen B; Ma Y
    PLoS One; 2014; 9(6):e100727. PubMed ID: 24956279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OmpW is a potential target for eliciting protective immunity against Acinetobacter baumannii infections.
    Huang W; Wang S; Yao Y; Xia Y; Yang X; Long Q; Sun W; Liu C; Li Y; Ma Y
    Vaccine; 2015 Aug; 33(36):4479-85. PubMed ID: 26207591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluationof the New Outer Membrane Protein A Epitope-based Vaccines for Mice Model of Acinetobacter baumannii Associated Pneumonia and Sepsis Infection.
    Mehdinejadiani K; Hashemi A; Bandehpour M; Rahmani H; Ranjbar MM; Yardel V; Jalali SA; Mosaffa N
    Iran J Allergy Asthma Immunol; 2021 Sep; 20(5):537-549. PubMed ID: 34664813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal immunization protects against Acinetobacter baumannii-associated pneumonia in mice.
    KuoLee R; Harris G; Yan H; Xu HH; Conlan WJ; Patel GB; Chen W
    Vaccine; 2015 Jan; 33(1):260-7. PubMed ID: 24699469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection.
    Luo G; Lin L; Ibrahim AS; Baquir B; Pantapalangkoor P; Bonomo RA; Doi Y; Adams MD; Russo TA; Spellberg B
    PLoS One; 2012; 7(1):e29446. PubMed ID: 22253723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small protein A and phospholipase D immunization serves a protective role in a mouse pneumonia model of Acinetobacter baumannii infection.
    Li H; Tan H; Hu Y; Pan P; Su X; Hu C
    Mol Med Rep; 2017 Aug; 16(2):1071-1078. PubMed ID: 28586022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infection.
    Huang W; Wang S; Yao Y; Xia Y; Yang X; Li K; Sun P; Liu C; Sun W; Bai H; Chu X; Li Y; Ma Y
    Sci Rep; 2016 Nov; 6():37242. PubMed ID: 27849050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoprotective potential of BamA, the outer membrane protein assembly factor, against MDR Acinetobacter baumannii.
    Singh R; Capalash N; Sharma P
    Sci Rep; 2017 Sep; 7(1):12411. PubMed ID: 28963492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii.
    Huang W; Yao Y; Wang S; Xia Y; Yang X; Long Q; Sun W; Liu C; Li Y; Chu X; Bai H; Yao Y; Ma Y
    Sci Rep; 2016 Feb; 6():20724. PubMed ID: 26853590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A lipopolysaccharide-free outer membrane vesicle vaccine protects against Acinetobacter baumannii infection.
    Pulido MR; García-Quintanilla M; Pachón J; McConnell MJ
    Vaccine; 2020 Jan; 38(4):719-724. PubMed ID: 31843268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal immunization with outer membrane vesicles (OMV) protects against airway colonization and systemic infection with Acinetobacter baumannii.
    Higham SL; Baker S; Flight KE; Krishna A; Kellam P; Reece ST; Tregoning JS
    J Infect; 2023 Jun; 86(6):563-573. PubMed ID: 36858180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A lethal pneumonia model of Acinetobacter baumannii: an investigation in immunocompetent mice.
    Zeng X; Gu H; Cheng Y; Jia KR; Liu D; Yuan Y; Chen ZF; Peng LS; Zou QM; Shi Y
    Clin Microbiol Infect; 2019 Apr; 25(4):516.e1-516.e4. PubMed ID: 30583061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological evaluation of OMV(PagL)+Bap(1-487aa) and AbOmpA(8-346aa)+Bap(1-487aa) as vaccine candidates against Acinetobacter baumannii sepsis infection.
    Badmasti F; Ajdary S; Bouzari S; Fooladi AA; Shahcheraghi F; Siadat SD
    Mol Immunol; 2015 Oct; 67(2 Pt B):552-8. PubMed ID: 26277277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vesicle-Mediated Dendritic Cell Activation in
    Cai W; Kesavan DK; Cheng J; Vasudevan A; Wang H; Wan J; Abdelaziz MH; Su Z; Wang S; Xu H
    J Immunol Res; 2019; 2019():2835256. PubMed ID: 32083139
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of Different Methods for Preparing
    Li S; Chen DQ; Ji L; Sun S; Jin Z; Jin ZL; Sun HW; Zeng H; Zhang WJ; Lu DS; Luo P; Zhao AN; Luo J; Zou QM; Li HB
    Front Immunol; 2020; 11():1069. PubMed ID: 32655550
    [No Abstract]   [Full Text] [Related]  

  • 16. Mucosal immunization with purified OmpA elicited protective immunity against infections caused by multidrug-resistant Acinetobacter baumannii.
    Zhang X; Yang T; Cao J; Sun J; Dai W; Zhang L
    Microb Pathog; 2016 Jul; 96():20-5. PubMed ID: 27133268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with lipopolysaccharide-deficient whole cells provides protective immunity in an experimental mouse model of Acinetobacter baumannii infection.
    García-Quintanilla M; Pulido MR; Pachón J; McConnell MJ
    PLoS One; 2014; 9(12):e114410. PubMed ID: 25485716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with recombinant DcaP-like protein and AbOmpA revealed protections against sepsis infection of multi-drug resistant Acinetobacter baumannii ST2
    Fereshteh S; Ajdary S; Sepehr A; Bolourchi N; Barzi SM; Haririzadeh Jouriani F; Riazi-Rad F; Shahcheraghi F; Badmasti F
    Microb Pathog; 2023 Jan; 174():105882. PubMed ID: 36403713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii.
    McConnell MJ; Rumbo C; Bou G; Pachón J
    Vaccine; 2011 Aug; 29(34):5705-10. PubMed ID: 21679737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Multiepitope Peptide, rOmp22, Encapsulated in Chitosan-PLGA Nanoparticles as a Candidate Vaccine Against
    Du X; Xue J; Jiang M; Lin S; Huang Y; Deng K; Shu L; Xu H; Li Z; Yao J; Chen S; Shen Z; Feng G
    Int J Nanomedicine; 2021; 16():1819-1836. PubMed ID: 33707942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.